en
Scientific article
English

Severity-adjusted icu mortality only tells half the truth — the impact of treatment limitation in a nationwide database

ContributorsKaufmann, Mark; Perren, Andréas; Cerutti, Bernardorcid; Dysli, Christine; Rothen, Hans Ulrich; Swiss Society of Intensive Care Medicine
Published inCritical care medicine, vol. 48, no. 12, p. e1242-e1250
First online date2020-10-08
Abstract

Objectives: The influence of different forms of treatment limitation on mortality rate in the ICU is not known despite the common use of the latter as a quality indicator. The aim of the present study was to assess the prevalence of treatment limitation and its influence on ICU mortality rate. Primary outcomes were prevalence of treatment limitation and its influence on severity-adjusted ICU mortality rate. Secondary outcomes included the association of limitation with age, sex, type of admission, diagnostic group, treatment intensity, and length of ICU stay.

Design: Retrospective, observational study.

Setting: All Swiss adult ICUs.

Interventions: None.

Patients: A total of 166,764 patients were admitted to an ICU in 2016 and 2017. Of these, 9139 were excluded because of readmission or invalid coding.

Measurements and main results: Of 157,625 ICU patients, 20,916 (13.3%) had a fully defined treatment limitation. Among this group, treatment limitation was defined upon ICU admission in 12,854 (61%), the decision to limit treatment was based on the patient's advance directives in 9,951 (48%), and in 15,341 (73%), there was a decision to deliberately withhold certain treatment modalities. The mortality odds ratio for the group with a treatment limitation, considering relevant cofactors, was 18.1 (95% CI 16.8-19.4).

Conclusions: Every seventh patient in a Swiss ICU has some kind of treatment limitation, and this most probably affects the severity-adjusted mortality rate. Thus, mortality data as a quality indicator or benchmark in intensive care can only meaningfully be interpreted if existence, grade, cause, and time of treatment limitation are taken into account.

eng
NoteComment in : Beane A, Dongelmans DA, Fernandez AL, Guidet B, Haniffa R, Arias Lopez MP, Pilcher D, Salluh J, Vijayaraghavan BKT; Linking of Global Intensive Care Collaboration (LOGIC). Time to Revisit Treatment Limitations in Critical Care Benchmarking. Crit Care Med. 2021 Apr 1;49(4):e472-e473. doi: 10.1097/CCM.0000000000004834. PMID: 33731631. Commented on : Kaufmann M, Cerutti B, Perren A. The authors reply. Crit Care Med. 2021 Apr 1;49(4):e474. doi: 10.1097/CCM.0000000000004904. PMID: 33731632.
Citation (ISO format)
KAUFMANN, Mark et al. Severity-adjusted icu mortality only tells half the truth — the impact of treatment limitation in a nationwide database. In: Critical care medicine, 2020, vol. 48, n° 12, p. e1242–e1250. doi: 10.1097/CCM.0000000000004658
Main files (2)
Article (Published version)
accessLevelRestricted
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal2432-2563
20views
0downloads

Technical informations

Creation03/22/2024 2:19:35 PM
First validation06/05/2024 8:35:42 AM
Update time06/05/2024 8:40:36 AM
Status update06/05/2024 8:40:36 AM
Last indexation06/05/2024 8:40:38 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack